Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India

Neelam Mohan1, Shivani Deswal2, Anubhuti Bhardwaj2

  • 1Department of Pediatric Gastroenterology, Hepatology and Liver Transplantation, Medanta - The Medicity Hospital, Sector - 38, Gurugram, 122 001, India. drneelam@yahoo.com.

Insights

Pediatric inflammatory bowel disease (IBD) is increasing in northern India, with ulcerative colitis more common than Crohn's disease. Diagnosis is often delayed, especially for Crohn's disease, with a rise in cases observed over two decades.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric inflammatory bowel disease (P-IBD) data from northern India is scarce, despite its prevalence in Western countries.
  • This study addresses the need for regional data on the clinical spectrum of P-IBD in northern India.

Purpose of the Study:

  • To analyze the clinical spectrum of pediatric inflammatory bowel disease (P-IBD) in northern India.
  • To identify trends and diagnostic challenges in P-IBD within the region.

Main Methods:

  • Retrospective analysis of 126 children (<18 years) diagnosed with IBD between 1999 and 2019.
  • Data collected via pre-designed proforma, entered into MS Excel, and analyzed using SPSS v21.0.
  • Phenotypes of Ulcerative Colitis (UC) and Crohn's Disease (CD) classified using the Paris classification.

Main Results:

  • Ulcerative Colitis (UC) diagnosed in 60.3%, Crohn's Disease (CD) in 34.9%, and IBD-unclassified (IBD-U) in 4.76%.
  • Mean age at diagnosis 11.3 years; 12.7% had very early onset IBD (VEOBD). Median time to diagnosis was 12 months, significantly longer (52.5 months) in CD.
  • Pancolitis with rectal bleeding (UC) and ileocolonic involvement with abdominal pain (CD) were common presentations. Stricturing disease seen in 27% of CD cases. A 2.75-fold rise in IBD cases noted in the last decade (2010-20).

Conclusions:

  • P-IBD is increasing in northern India, with UC more prevalent than CD.
  • Significant delays in diagnosis, particularly for CD, were observed.
  • Pancolitis and ileocolonic disease are common sites for UC and CD, respectively, with stricturing disease a notable feature in CD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
259
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
458
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
134
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
149